Ameritas Investment Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,245
| Closed | -$597K | – | 3198 |
|
|
2021
Q1 | $597K | Sell |
5,245
-47
| -0.9% | -$5.35K | 0.02% | 739 |
|
|
2020
Q4 | $733K | Buy |
5,292
+391
| +8% | +$54.2K | 0.03% | 661 |
|
|
2020
Q3 | $403K | Sell |
4,901
-110
| -2% | -$9.05K | 0.02% | 771 |
|
|
2020
Q2 | $392K | Buy |
5,011
+157
| +3% | +$12.3K | 0.02% | 776 |
|
|
2020
Q1 | $216K | Buy |
4,854
+208
| +4% | +$9.26K | 0.01% | 896 |
|
|
2019
Q4 | $198K | Hold |
4,646
| – | – | 0.01% | 1093 |
|
|
2019
Q3 | $199K | Hold |
4,646
| – | – | 0.01% | 1055 |
|
|
2019
Q2 | $295K | Buy |
4,646
+293
| +7% | +$18.6K | 0.01% | 879 |
|
|
2019
Q1 | $302K | Buy |
4,353
+400
| +10% | +$27.8K | 0.01% | 865 |
|
|
2018
Q4 | $172K | Hold |
3,953
| – | – | 0.01% | 1045 |
|
|
2018
Q3 | $302K | Hold |
3,953
| – | – | 0.01% | 878 |
|
|
2018
Q2 | $304K | Buy |
3,953
+191
| +5% | +$14.7K | 0.01% | 864 |
|
|
2018
Q1 | $192K | Buy |
3,762
+288
| +8% | +$14.7K | 0.01% | 1096 |
|
|
2017
Q4 | $161K | Hold |
3,474
| – | – | 0.01% | 1210 |
|
|
2017
Q3 | $198K | Hold |
3,474
| – | – | 0.01% | 1070 |
|
|
2017
Q2 | $216K | Buy |
3,474
+248
| +8% | +$15.4K | 0.01% | 1022 |
|
|
2017
Q1 | $219K | Buy |
3,226
+115
| +4% | +$7.81K | 0.01% | 1007 |
|
|
2016
Q4 | $219K | Hold |
3,111
| – | – | 0.01% | 997 |
|
|
2016
Q3 | $221K | Buy |
+3,111
| New | +$221K | 0.01% | 965 |
|
|
2016
Q1 | – | Sell |
-3,021
| Closed | -$339K | – | 1184 |
|
|
2015
Q4 | $339K | Hold |
3,021
| – | – | 0.02% | 756 |
|
|
2015
Q3 | $291K | Buy |
3,021
+250
| +9% | +$24.1K | 0.02% | 781 |
|
|
2015
Q2 | $284K | Buy |
+2,771
| New | +$284K | 0.02% | 838 |
|